Calliditas Therapeutics — Major Shareholding Notification 2019

Jul 4, 2019

Issuer Calliditas Therapeutics AB

Holder

Investinor AS

Instrument

Instrument	Ordinary shares SE0010441584
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	03/07/2019
Limit for number of shares	15 %
Limit for number of votes	15 %
After the transaction
Quantity
Shares	5,091,243
Directly held voting rights	5,091,243
Indirectly held voting rights	0
Percentage
Directly held shares	13.15307 %
Directly held voting rights	13.15307 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	13.15307 %	5,091,243
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	13.15307 %	5,091,243
Group total holdings

Voting rights 5,091,243 Percentage of voting rights 13.15307

Notes (other relevant informations according to law)

Flaggning baseras på det nya antalet aktier i Calliditas Therapeutics AB efter registrering av dess nyemission som offentliggjordes den 3 juli 2019.

Published

04/07/2019 10:17

Contact

Name Tor Helmersen Phone +4795742000 Email post@investinor.no

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25